Medical Microbiology articles for India

Time frame: 1 June 2025 - 30 May 2026

View topic

Count: 34

Article ‘Count’ for Medical Microbiology.

Journal Count Share
2 0.26
Combinatorial Synthesis of Next Generation Water‐Soluble Quaternized N‐Halamine Oligomers with Long‐Lasting Antiviral Properties 0.13
Host-Guest Inclusion Chemistry From Supramolecular Architecture Enabling Anti-Biofouling Surfaces for Oesophagus Stents 0.13
5 1.03
<atl>Trends in Antifungal Resistance and Mechanistic Insights Into Azole Resistance in iCandida (candidozyma) auris/i : A 13-Year Study of a Comprehensive Set of Clinical Isolates From India</atl> 0.67
Immunogenicity and Safety of Co-administration of Adjuvanted Respiratory Syncytial Virus Prefusion F Protein Vaccine With 20-Valent Pneumococcal Conjugate Vaccine in Adults Aged ≥60 Years: A Randomized, Non-inferiority Trial 0.09
When are uncontrolled trials in TB scientifically and ethically justified: Borrowing wisdom from early AIDS clinical trials 0.07
Health-related Quality of Life in European Older Adults with Respiratory Syncytial Virus Over Three Respiratory Syncytial Virus Seasons 0.09
Burden of Respiratory Syncytial Virus Among Older Adults With an Acute Respiratory Infection: A Prospective Study in Six European Countries 0.11
1 1.00
Genomic determinants across cross- and co-resistance events of the environmental resistome of Klebsiella pneumoniae 1.00
1 0.92
Microemulsion-Assisted Synthesis of Ni(II)-Grafted Cellulose Metallogel: Structural Insights into a High-Performance β-Lactamase Inhibitor 0.92
3 2.53
A prokaryotic-like cardiolipin synthase is essential to maintain mitochondrial function, lipid homeostasis, and survival of the blood stage malaria parasite Plasmodium falciparum 0.78
A secreted Leishmania metalloprotease manipulates host iron regulation by targeting the DICER1–miRNA pathway 1.00
SA-XV, a 15-amino acid fragment of host defense peptide S100A12, targets mitochondria and is protective against fungal infections 0.75
5 2.88
Host Reticulocyte Redox Attenuation Creates a Protective Niche for Artemisinin Tolerance in Plasmodium falciparum 0.77
<atl>Safety and Immunogenicity of a Trivalent iSalmonella/i Conjugate Vaccine to iS./i Typhi, iS./i Typhimurium, and iS./i Enteritidis</atl> 0.25
High Seropositivity to rK39 and Capture of Leishmania-Infected Sand Flies in Bihar and Jharkhand Emphasize the Need for Post-Elimination Surveillance of Visceral Leishmaniasis in India 0.71
Essential Role of Clathrin and Lipid Rafts in pH-dependent Entry of Chandipura Virus: Independence From Caveolin Pathway 0.81
Human Metapneumovirus, Respiratory Syncytial Virus and Influenza Associated Pneumonia Hospitalizations in Colorado Adults Aged Over 50 Years: 2016-2023 0.33
7 4.89
Carbapenemase-producing carbapenem-resistant Enterobacterales in surgical intensive care unit patients in a tertiary hospital in India 0.43
Gut microbiome features associated with Bifidobacterium colonization predict personalized probiotic persistence patterns 0.71
Robust antibiotic sensitization of pathogenic Pseudomonas aeruginosa via negative hysteresis in the cell envelope 0.02
Spike conformational and glycan heterogeneity associated with furin cleavage causes incomplete neutralization of SARS-CoV-2 0.87
Bioenergetic reprogramming of macrophages reduces drug tolerance in Mycobacterium tuberculosis 0.86
Fundamental role of spatial positioning of Mycobacterium tuberculosis in mycobacterial survival in macrophages 1.00
Cryo-EM structure of ribosome from pathogenic protozoa reveals unique features of its architecture 1.00
2 1.20
A combination typhoid and non-typhoidal polysaccharide conjugate vaccine in healthy adults: a randomized, placebo-controlled phase 1 trial 0.22
Impact of the indigenous rotavirus vaccine Rotavac in the Universal Immunization Program in India during 2016–2020 0.98
1 1.00
Impeding pathways of intrinsic resistance in Escherichia coli confers antibiotic sensitization and resistance proofing 1.00
1 0.01
SARS-CoV-2 peptide fragments selectively dysregulate specific immune cell populations via Gaussian curvature targeting 0.01
1 1.00
Efficacy and safety of VPM1002 and Immuvac in preventing tuberculosis: phase 3 randomised clinical trial (PreVenTB trial) 1.00
1 1.00
Protease-Mediated Shedding and Intermittent Mobility of the SARS-CoV-2 Delta Variant 1.00
1 0.20
Feasibility of interrupting the transmission of soil-transmitted helminths: the DeWorm3 community cluster-randomised controlled trial in Benin, India, and Malawi 0.20
1 0.02
Effectiveness of the RTS,S/AS01E malaria vaccine in a real-world setting over 1 year of follow-up after the three-dose primary schedule: an interim analysis of a phase 4 study in Ghana, Kenya, and Malawi 0.02
2 0.17
Phase 3 Results of Bepirovirsen Treatment for Chronic Hepatitis B Virus Infection 0.02
Safety, Efficacy, and Immunogenicity of a Salmonella Paratyphi A Vaccine 0.15

Numerical information only (in the tables above) is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International.